Cargando…

30 mCi exploratory scan for two-step dosimetric (131)I therapy in differentiated thyroid cancer patients: A novel approach and case report

Differentiated thyroid cancer patients with significantly elevated or rapidly rising serum thyroglobulin (Tg) levels and negative diagnostic radioiodine scans (DxScan) often present a therapeutic dilemma in deciding whether or not to administer an (131)I treatment. In this report, we describe a nove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Di, Gomes-Lima, Cristiane Jeyce, Kulkarni, Kanchan, Burman, Kenneth D., Wartofsky, Leonard, Van Nostrand, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745862/ https://www.ncbi.nlm.nih.gov/pubmed/33354183 http://dx.doi.org/10.4103/wjnm.WJNM_35_19

Ejemplares similares

Efficacy of Dosimetric Versus Empiric Prescribed Activity of (131)I for Therapy of Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011)

Fixed 30 mCi (1110 MBq) (131)I-iodine therapy in autonomously functioning nodules: Single toxic nodule as a predictive factor of success
por: Pereira, Lívia Stela Bueno, et al.
Publicado: (2021)

Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2022)

Outcomes following I-131 treatment with cumulative dose exceeding or equal to 600 mCi in differentiated thyroid carcinoma patients
por: Kaewput, Chalermrat, et al.
Publicado: (2020)

Can Reverse T3 Assay Be Employed to Guide T4 vs. T4/T3 Therapy in Hypothyroidism?
por: Gomes-Lima, Cristiane, et al.
Publicado: (2019)

Response to Letter to the Editor from Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2023)

Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation
por: Jeon, Eon Ju, et al.
Publicado: (2014)

Predictive value of pyramidal lobe, percentage thyroid uptake and age for ablation outcome after 15 mCi fixed dose of radioiodine-131 in Graves’ disease
por: Zaman, Maseeh uz, et al.
Publicado: (2015)

Microfluidic Droplet Digital PCR Is a Powerful Tool for Detection of BRAF and TERT Mutations in Papillary Thyroid Carcinomas
por: Ylli, Dorina, et al.
Publicado: (2019)

Levothyroxine Treatment in Pregnancy: Indications, Efficacy, and Therapeutic Regimen
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011)

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy
por: Súss, Shirlei Kugler Aiçar, et al.
Publicado: (2018)

Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy
por: Jensen, Kirk, et al.
Publicado: (2020)

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
por: Kukulska, Aleksandra, et al.
Publicado: (2010)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
por: Kukulska, Aleksandra, et al.
Publicado: (2020)

Two themes in thyroid cancer: artful diagnosis and shortened lives
por: Lima, Cristiane Gomes, et al.
Publicado: (2022)

Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders”
por: Ylli, Dorina, et al.
Publicado: (2021)

Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2018)

Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
por: Jeon, Eon Ju, et al.
Publicado: (2014)

Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
por: Jung, Chan-Hee
Publicado: (2014)

Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2017)

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI †
por: Zhao, Yan, et al.
Publicado: (2022)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models
por: Josefsson, Anders, et al.
Publicado: (2014)

Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
por: Yondorf, Menachem Z., et al.
Publicado: (2020)

Feasibility and long-term results of focused radioguided parathyroidectomy using a "low" 37 MBq (1 mCi) (99m)Tc-sestamibi protocol
por: Rubello, Domenico, et al.
Publicado: (2006)

MON-551 Immediate Cause Of Death In Patients With Thyroid Cancer Progression
por: Ylli, Dorina, et al.
Publicado: (2019)

Ci siamo!
Publicado: (2008)

Determination of administered activities for the treatment of Graves' disease with iodine-131: Proposition of a simplified dosimetric procedure
por: Soli, Idrissa Adamou, et al.
Publicado: (2021)

Unexpected Uptake by the Gallbladder in Post-Ablative I-131 Scan
por: Ünal, Kemal, et al.
Publicado: (2015)

Inguinal Endometriosis Visualized on I-131 Whole Body Scan
por: Çayır, Derya, et al.
Publicado: (2018)

Agenda for the 131st Meeting on 29 and 30 May 1990
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1990)

Number of Foci of Functioning Thyroid Tissue Remaining after Thyroidectomy for Differentiated Thyroid Cancer: Institutional Experience
por: Kulkarni, Kanchan, et al.
Publicado: (2017)

Determination of dosimetric quantities in pediatric abdominal computed tomography scans
por: Jornada, Tiago da Silva, et al.
Publicado: (2014)

MON-556 Sex-Bias in Clinicopathological Presentation of Patients with Differentiated Thyroid Cancer
por: Shobab, Leila, et al.
Publicado: (2019)

Decisions taken at the 131st Meeting on 29 and 30 May 1990
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1990)

Stunning in post (131)I therapy scans after low-dose (131)I diagnostic whole body scans with differentiated thyroid cancer in the Indian patient population: Critical importance of interval between the two scans
por: Damle, Nishikant A., et al.
Publicado: (2012)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Microcystin mcyA and mcyE Gene Abundances Are Not Appropriate Indicators of Microcystin Concentrations in Lakes
por: Beversdorf, Lucas J., et al.
Publicado: (2015)

CiTO, the Citation Typing Ontology
por: Shotton, David
Publicado: (2010)

Che ci faccio qui?
por: Chatwin, Bruce, 1940-1989

Cannot write session to /tmp/vufind_sessions/sess_r9j5ul229du1qapml36ggcobnu